HIDDEN BURDEN OF CORONARY MICROVASCULAR DISEASE IN A DIABETIC FEMALE NSTEMI PATIENT : A CASE-BASED CLINICAL PERSPECTIVE

Authors

  • Dorena Kasego Faculty of Medicine, Universitas Tarumanagara, Jakarta, Indonesia
  • Pujo Hendriyanto Department of Internal Medicine, KRMT Wongsonegoro Regional General Hospital, Semarang, Indonesia
  • Velma Herwanto Department of Internal Medicine, Faculty of Medicine, Universitas Tarumanagara, Jakarta, Indonesia

DOI:

https://doi.org/10.31004/prepotif.v9i2.46388

Keywords:

diabetes melitus, pasien perempuan, disfungsi endotel, infark miokard non-ST elevasi, penyakit mikrovaskular koroner

Abstract

Penyakit mikrovaskular koroner (Coronary Microvascular Disease/CMD) semakin dikenal sebagai penyebab iskemia miokard pada pasien tanpa penyakit arteri koroner obstruktif, terutama pada perempuan dengan diabetes. Infark miokard non-ST elevasi (NSTEMI) dalam kelompok ini sering muncul dengan gejala atipikal dan temuan elektrokardiografi yang tidak spesifik, sehingga menyulitkan diagnosis dan penanganan yang tepat waktu  Seorang perempuan usia 50 tahun dengan riwayat diabetes melitus dan hipertensi datang dengan keluhan nyeri dada yang berlangsung lama tanpa elevasi segmen ST pada elektrokardiogram. Evaluasi kardiak menunjukkan NSTEMI anterior, namun tidak ditemukan obstruksi pada pembuluh koroner epikardial. Karakteristik klinis dan demografis pasien mengarah pada dugaan disfungsi mikrovaskular koroner. Pasien ditatalaksana secara konservatif dengan terapi antiplatelet ganda, antihipertensi, dan pengendalian metabolik. Kasus ini menggambarkan permasalahan tersembunyi CMD pada perempuan dengan diabetes, di mana cedera iskemik dapat terjadi meskipun hasil angiografi tampak normal. CMD melibatkan disfungsi endotel, penurunan cadangan aliran koroner, dan aktivasi inflamasi, yang semakin nyata dalam kondisi diabetes. Alat diagnostik konvensional seringkali tidak memadai untuk mendeteksi CMD, sehingga diperlukan kecurigaan klinis yang tinggi. CMD perlu dipertimbangkan pada perempuan dengan diabetes yang mengalami NSTEMI, terutama jika perubahan elektrokardiografi minimal dan wilayah infark melibatkan miokard anterior. Pengakuan dini dan terapi yang ditargetkan sangat penting untuk menurunkan risiko kardiovaskular jangka panjang pada subpopulasi berisiko tinggi ini.

References

Al-Rousan, T., AlHeresh, R., Saadi, A., El-Sabrout, H., Young, M., Benmarhnia, T., et al. (2022). Epidemiology of cardiovascular disease and its risk factors among refugees and asylum seekers: Systematic review and meta-analysis. International Journal of Cardiology: Cardiovascular Risk and Prevention, 12, 200126. https://doi.org/10.1016/j.ijcrp.2022.200126

Al-Saffar, H. B., Nassir, H., Mitchell, A., & Philipp, S. (2015). Microalbuminuria in non-diabetic patients with unstable angina/non ST-segment elevation myocardial infarction. BMC Research Notes, 8, 371. https://doi.org/10.1186/s13104-015-1347-x

Basile, U., La Rosa, G., Napodano, C., Pocino, K., Cappannoli, L., Gulli, F., et al. (2019). Free light chains a novel biomarker of cardiovascular disease. A pilot study. European Review for Medical and Pharmacological Sciences, 23(6), 2563–2569. https://doi.org/10.26355/eurrev_201903_17405

Berman, N., Jones, M. M., & De Coster, D. A. (2017). “Just like a normal pain”, what do people with diabetes mellitus experience when having a myocardial infarction: a qualitative study recruited from UK hospitals. BMJ Open, 7(9), e015736. https://doi.org/10.1136/bmjopen-2016-015736

Bertoluci, M. C., Salles, J. E. N., Silva-Nunes, J., Pedrosa, H. C., Moreira, R. O., & da Silva Duarte, R. M. C., et al. (2020). Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus. Diabetology & Metabolic Syndrome, 12, 45. https://doi.org/10.1186/s13098-020-00551-1

Bruch, L., Zadura, M., Waliszewski, M., Platonic, Z., Eränen, J., Scheller, B., et al. (2016). Results From the International Drug Coated Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated Without Stents? Journal of Interventional Cardiology, 29(4), 348–356. https://doi.org/10.1111/joic.12301

Cha, J. J., Bae, S., Park, D. W., Park, J. H., Hong, S. J., Park, S. M., et al. (2022). Clinical Outcomes in Patients With Delayed Hospitalization for Non-ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology, 79(4), 311–323. https://doi.org/10.1016/j.jacc.2021.11.019

Chhabra, S. T., Kaur, T., Masson, S., Soni, R. K., Bansal, N., Takkar, B., et al. (2018). Early onset ACS: An age based clinico-epidemiologic and angiographic comparison. Atherosclerosis, 279, 45–51. https://doi.org/10.1016/j.atherosclerosis.2018.10.017

Chowdhury, M. T., Hoque, H., Mahmood, M., Khaled, F. I., Iqbal, K. M., Mostafa, Z., et al. (2020). Improvement of Left Ventricular Systolic Function after Percutaneous Coronary Intervention in Diabetic Patients with Non-ST elevated Myocardial Infarction. Mymensingh Medical Journal, 29(2), 384–391.

Cole, A., Weight, N., Misra, S., Grapsa, J., Rutter, M. K., Siudak, Z., et al. (2024). Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study. Diabetologia, 67(12), 2711–2725. https://doi.org/10.1007/s00125-024-06281-7

Dąbek, J., Bałys, M., Majewski, M., & Gąsior, Z. T. (2016). Diabetic Patients with an Acute Myocardial Infarction in Terms of Risk Factors and Comorbidities Management: Characteristics of the Highest-Risk Individuals. Advances in Clinical and Experimental Medicine, 25(4), 655–663. https://doi.org/10.17219/acem/58785

Deedwania, P., Acharya, T., Kotak, K., Fonarow, G. C., Cannon, C. P., Laskey, W. K., et al. (2017). Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association’s Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program. American Heart Journal, 187, 78–87. https://doi.org/10.1016/j.ahj.2017.02.025

Elshorbagy, A., Vallejo-Vaz, A. J., Barkas, F., Lyons, A. R. M., Stevens, C. A. T., Dharmayat, K. I., et al. (2025). Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae791

Fonseca, H. A. R., Izar, M. C. O., Drager, L. F., Pinto, I. M., Saraiva, J. F. K., Ferreira, J. F. M., et al. (2023). Primary Prevention of Cardiovascular Disease at Community Clinics in the State of Sao Paulo, Brazil: Results from the Epidemiological Information Study of Communities. Global Heart, 18(1), 24. https://doi.org/10.5334/gh.1203

Gouda, P., Savu, A., Bainey, K. R., Kaul, P., & Welsh, R. C. (2021). Long-term risk of death and recurrent cardiovascular events following acute coronary syndromes. PLoS ONE, 16(7), e0254008. https://doi.org/10.1371/journal.pone.0254008

Hassan, W., Saquib, J., Khatri, M., Kazmi, S. K., Kotak, S., Hassan, H., et al. (2022). Short- and long-term cardiovascular outcomes in insulin-treated versus non-insulin-treated diabetes mellitus patients after percutaneous coronary intervention: A systematic review and meta-analysis. Indian Heart Journal, 74(1), 13–21. https://doi.org/10.1016/j.ihj.2021.12.004

He, Z., Cheng, H., Jia, Z., Niu, Z., Li, Y. T., & Huang, W., et al. (2025). Biomedical outcomes and cardiovascular risks in Chinese adults with type 2 diabetes in the metabolic management center program: A longitudinal comparative study. Journal of Diabetes Investigation, 16(5), 884–892. https://doi.org/10.1111/jdi.14414

Hu, C., Wang, S., Lin, H., Wan, Q., Zheng, R., Zhu, Y., et al. (2024). Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study. Diabetes, Obesity and Metabolism, 26(6), 2176–2187. https://doi.org/10.1111/dom.15525

Hryhoriy, K. (2016). Peculiarities of heart rate in the patients with unstable angina and non-ST elevation myocardial infarction and concomitant diabetes mellitus type 2. Wiadomości Lekarskie, 69(3 Pt 2), 524–526.

Khalil, M. A., Khalfallah, M., & Elsheikh, A. (2024). Predictors and clinical outcomes of slow flow phenomenon in diabetic patients with chronic coronary syndrome. BMC Cardiovascular Disorders, 24(1), 518. https://doi.org/10.1186/s12872-024-04164-8

Kobo, O., Marcusohn, E., Roguin, A., Zukermann, R., Amsalem, N., & Nikolsky, E., et al. (2021). Prognosis of Patients With Left Circumflex Artery Acute Myocardial Infarction in Relation to ST-Segment

Downloads

Published

2025-07-02

How to Cite

Kasego, D., Hendriyanto, P., & Herwanto, V. (2025). HIDDEN BURDEN OF CORONARY MICROVASCULAR DISEASE IN A DIABETIC FEMALE NSTEMI PATIENT : A CASE-BASED CLINICAL PERSPECTIVE. PREPOTIF : JURNAL KESEHATAN MASYARAKAT, 9(2), 3622–3627. https://doi.org/10.31004/prepotif.v9i2.46388